Follow-up of men with an elevated PCA3 score and a negative biopsy: Does an elevated PCA3 score indeed predict the presence of prostate cancer?

BJU International

Volumn 106, Issue 8, 2010, Pages 1138-1142

  Remzi, Mesut ^a   Haese, Alexander ^b   Van Poppel, Hein ^d   De La Taille, Alexandre ^e   Stenzl, Arnulf ^c   Hennenlotter, Jörg ^c   Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

biopsy; follow up; high grade prostatic intraepithelial neoplasia; PCA3; prostate; prostate cancer

Indexed keywords

PROSTATE CANCER GENE 3 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SCORING SYSTEM; TUMOR BIOPSY;

AGED; ANTIGENS, NEOPLASM; BIOPSY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957605089     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09330.x     Document Type: Article

References (21)

1. Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009 360 : 1320 8
2. Bussemakers MJ, van Bokhoven A, Verhaegh GW et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999 59 : 5975 9
3. PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003 44 : 8 16
4. Groskopf J, Aubin SM, Deras IL et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006 52 : 1089 95
5. Marks LS, Fradet Y, Deras IL et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 2007 69 : 532 5
6. Haese A, de la Taille A, Van Poppel H et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 2008 54 : 1081 8
7. Deras IL, Aubin SM, Blase A et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 2008 179 : 1587 92
8. Nakanishi H, Groskopf J, Fritsche HA et al. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. J Urol 2008 179 : 1804 9
9. Whitman EJ, Groskopf J, Ali A et al. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. J Urol 2008 180 : 1975 8
10. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006 61 : 142 53
11. Seitz C, Palermo S, Djavan B. Prostate biopsy. Minerva Urol Nefrol 2003 55 : 205 18
12. Djavan B, Ravery V, Zlotta A et al. Prospective evaluation of prostate cancer detected on biopsies1,2,3 and4: when should we stop? J Urol 2001 166 : 1679 83
13. Shappell SB, Fulmer J, Arguello D, Wright BS, Oppenheimer JR, Putzi MJ. PCA3 urine mRNA testing for prostate carcinoma. Patterns of use by community urologists and assay performance in reference laboratory setting. Urology 2009 73 : 363 8
14. Chun FK, de la Taille A, Van Poppel H et al. Prostate cancer gene3 (PCA3): development and internal validation of a novel biopsy nomogram. Eur Urol 2009 56 : 659 67
15. Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol 2009 6 : 255 61
16. Popa I, Fradet Y, Beaudry G, Hovington H, Beaudry G, Tetu B. Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization. Mod Pathol 2007 20 : 1121 7
17. Brawer MK. Prostatic intraepithelial neoplasia: an overview. Rev Urol 2005 7 (Suppl. 3 S11 18
18. Schoenfield L, Jones JS, Zippe CD et al. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007 99 : 770 4
19. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006 175 : 820 34
20. European Association of Urology. EAU guidelines on prostate cancer 2009. Available at: http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/ Prostate-Cancer.pdf. Accessed July 2009
21. Chun FKH, Briganti A, Shariat SF et al. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int 2006 98 : 329 34